C16OH-KGK

General Information


DRACP ID  DRACP03587

Peptide Name   C16OH-KGK

Sequence  KGK

Sequence Length  3

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP03587

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  3-OH-C16

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C14H29N5O4

Absent amino acids  ACDEFHILMNPQRSTVWY

Common amino acids  K

Mass  36727

Pl  10.81

Basic residues  2

Acidic residues  0

Hydrophobic residues  0

Net charge  2

Boman Index  -1016

Hydrophobicity  -273.33

Aliphatic Index  0

Half Life 
  Mammalian: 1.2 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 27486068

Title  Ultrashort cationic lipopeptides and lipopeptoids: Evaluation and mechanistic insights against epithelial cancer cells

Doi Not available

Year  2016

Literature 2

Pubmed ID 22578748

Title  Investigating the antimicrobial peptide 'window of activity' using cationic lipopeptides with hydrocarbon and fluorinated tails

Doi Not available

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  7948

DRACP is developed by Dr.Zheng's team.